• Toll Free: +1- 844-445-2861
  •   sales@futuregenicreports.com

Medical Devices

 
North America Powered Surgical Instruments Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Powered Surgical Instruments is a market of technological devices used to assist in the performance of orthopaedic and neurological surgeries. Product categories of powered surgical instruments include pneumatic large bone equipment, battery/electric large bone equipment, pneumatic small bone equipment, electric small bone equipment and high speed equipment. Surgeons often employ surgical drills, saws, clip appliers and surgical staplers in surgery and RF electrosurgery systems are routinely used to cut and cauterize tissue in nearly all types of surgical procedures.

Scope of the Report:
This report focuses on the Powered Surgical Instruments in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Stryker
Johnson & Johnson
B. Braun
Medtronic
Conmed
Smith & Nephew
Zimmer Biomet
De Soutter Medical
Pro-Dex

Market Segment by Countries, covering
Electric-powered
Battery-powered
Pneumatic-powered

Market Segment by Type, covers
Orthopedic
ENT
Cardiothoracic
Neurology
Other

Market Segment by Applications, can be divided into
Orthopedic
ENT
Cardiothoracic
Neurology
Other

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Spinal Cord Stimulation Devices Market 2018 Forecast to 2023

"Spinal Cord Stimulation Devices is ....

Scope of the Report:
This report focuses on the Spinal Cord Stimulation Devices in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Agilent
Thermo Fisher
Shimadzu
Waters
Showa Denko K.K.
PerkinElmer
GL Sciences
Bio-rad
Metrohm
Jasco

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
UV-Visible Detectors
Refractive Index Detectors
ELSD Detectors
Fluorescence Detectors
Other

Market Segment by Applications, can be divided into
Liquid Chromatography
HPLC
UHPL

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Metabolite Chemistry Reagents Market 2018 Forecast to 2023

"This report studies the Metabolite Chemistry Reagents market, from angles of players, regions, product types and end industries, to analyze the status and the future. Metabolite Chemistry Reagents refers to diagnostic reagent that is used in vitro or in vivo for detection or screening of a particular metabolite reactions.

Scope of the Report:
This report focuses on the Metabolite Chemistry Reagents in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
BioVision
Merck
Thermo Fisher Scientific
BD
Abbott
Kerafast
Beijing Strong Biotechnologies
Pointe Scientific
Luxcel Biosciences
Randox Laboratories Limited
Beijing Leadman Biochemistry
Shenzhen Bioeasy Biotechnology
Shenzhen Lvshiyuan Biotechnology
BioSino
NITTO BOSEKI

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Glycometabolism
Amino Acid Metabolism
Fatty Acid/Cholesterol Metabolism
Others

Market Segment by Applications, can be divided into
Diabetes
Obesity
Others

Published

Read more
United States Test Phantoms Market by Manufacturers, States, Type and Application, Forecast to 2023

"""This report studies the Test Phantoms market, Test Phantoms can ensure your patients are receiving maximum image quality at the lowest possible dose.
""

Scope of the Report:
This report focuses on the Test Phantoms in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers""
Gammex
Fluke
IBA
Standard Imaging
Biodex Medical Systems
RaySafe
Capintec
Pro-Project
The Phantom Laboratory
Carville
CIRS
Modus Medical Devices
Radiology Support Devices
3-Dmed
Kyoto Kagaku
Other

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Market Segment by Type, covers
CT Test Phantoms
Mammography Test Phantoms
Ultrasound Test Phantoms
Radiation Oncology Test Phantoms
MRI Test Phantoms
Others

Market Segment by Applications, can be divided into
Research institute
School
Hospital
Others

 

Published

Read more
United States Rollator Walker Market by Manufacturers, States, Type and Application, Forecast to 2023

"""Rollator Walker which is also named as the rolling walking, rollator is a walker with a wheel at the bottom of each leg. There are 3 wheel rollators and 4 wheel rollators, and most have some kind of a pouch or basket to carry your things. Rollators are perfect for use outdoors where the surfaces may be uneven. They can also be used indoors, and some are even narrow enough to navigate through tricky halls and doorways.
""
Scope of the Report:
This report focuses on the Rollator Walker in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers""
Graham-Field
Drive DeVilbiss Healthcare
Karman
Human Care
Meyra
Roscoe Medical
Kaiyang Medical Technology
Evolution Technologies
Dongfang
Briggs Healthcare
Matsunaga
Cardinal Health
Trionic Sverige
Handicare
Invacare
Thuasne
TOPRO
Access
Bischoff & Bischoff
HomCom
Medline Industries
Nova
TrustCare

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Market Segment by Type, covers
3 Wheel Rollators
4 Wheel Rollators
Others

Market Segment by Applications, can be divided into
65 to 85years Old
Above 85 Years Old
Young Population

 

Published

Read more
Global Glucose Meter Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Scope of the Report:
This report focuses on the Glucose Meter in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Roche
JNJ
Bayer
Abbott
Omron
Arkray
Grace
B.Braun
I-SENS,Inc
Infopia Co., Ltd
Hainice Medical Inc
Mendor
All Medicus Co.,Ltd
77 Elektronika Müszeripari Kft
Delta Group
Ok Biotech
Medisana
FIFTY50(USA)
Nova Biomedical(USA)
Oak Tree Tree Health, Inc.(USA)
Omnis Health(USA)
Simple Diagnostics(USA)
US Diagnostics(USA)
SD Biosensor, INC(Korea)
Nipro
Terumo Corporation
Homemed (Pty) Ltd(South Africa)
Sannuo
Yuwell Medical
YICHENG

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
0.5uL/0.6uL
1uL
1.5uL
Others

Market Segment by Applications, can be divided into
Medical
Home Care

Published

Read more
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Eye Anatomical Model Market 2018 Forecast to 2023

"Eye Anatomical Model is a kind of models to study and explain the internal and external structure of the eyes. Students interested in the medical profession as well as doctors, professors, and health care professionals profit from the realism of the models.

Scope of the Report:
This report focuses on the Eye Anatomical Model in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
3B Scientific
SOMSO
GPI Anatomicals
Erler-Zimmer
Edutek Instrumentation
Sakamoto Model Corporation
Honglian Medical Tech
RUDIGER - ANATOMIE
Xincheng
Altay Scientific
Kanren
Denoyer-Geppert
Nasco
Educational + Scientific Products Ltd
Dynamic Tracom

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Small Size Eye Anatomical Model
Large Size Eye Anatomical Model

Market Segment by Applications, can be divided into
Education
Hospitals
Clinic
Other

Published

Read more
Global Intranasal Drug Delivery Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.

Scope of the Report:
This report focuses on the Intranasal Drug Delivery Devices in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
BD
AptarGroup
3M
Teleflex
H&T Presspart
Bespak

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Multidose
Uni/bidose

Market Segment by Applications, can be divided into
Personal Use
Hospital Use

Published

Read more
Global Joint Replacement Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Replacement arthroplasty, or joint replacement surgery, is a procedure of orthopedic surgery in which an arthritic or dysfunctional joint surface is replaced with an orthopedic prosthesis. Joint replacement is considered as a treatment when severe joint pain or dysfunction is not alleviated by less-invasive therapies. It is a form of arthroplasty, and is often indicated from various joint diseases, including osteoarthritis and rheumatoid arthritis.

Scope of the Report:
This report focuses on the Joint Replacement in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Zimmer Biomet
Stryker
DePuy Synthes
Smith & Nephew
Wright Medical
Exactech
Integra
Aesculap
Arthrex

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Knees
Hips
Extremities

Market Segment by Applications, can be divided into
Age Below 45
Age 45-64
Age above 65

Published

Read more
Global Refractive Surgery Devices Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Refractive eye surgery is any eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. This can include various methods of surgical remodeling of the cornea or cataract surgery. The most common methods today use excimer lasers to reshape the curvature of the cornea. Successful refractive eye surgery can reduce or cure common vision disorders such as myopia, hyperopia and astigmatism, as well as degenerative disorders like keratoconus.

Scope of the Report:
This report focuses on the Refractive Surgery Devices in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Alcon (Novartis)
J &J
Zeiss
Bausch and Lomb (Valeant)
Ziemer Ophthalmic
Avedro
Nidek
Lensar
SCHWIND
iVIS Technologies

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Excimer Laser Systems
Femtosecond Laser System
Other

Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Ophthalmology Clinics

Published

Read more
Global Powered Surgical Instruments Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Powered Surgical Instruments is a market of technological devices used to assist in the performance of orthopaedic and neurological surgeries. Product categories of powered surgical instruments include pneumatic large bone equipment, battery/electric large bone equipment, pneumatic small bone equipment, electric small bone equipment and high speed equipment. Surgeons often employ surgical drills, saws, clip appliers and surgical staplers in surgery and RF electrosurgery systems are routinely used to cut and cauterize tissue in nearly all types of surgical procedures.

Scope of the Report:
This report focuses on the Powered Surgical Instruments in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Stryker
Johnson & Johnson
B. Braun
Medtronic
Conmed
Smith & Nephew
Zimmer Biomet
De Soutter Medical
Pro-Dex

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Electric-powered
Battery-powered
Pneumatic-powered

Market Segment by Applications, can be divided into
Orthopedic
ENT
Cardiothoracic
Neurology
Other

Published

Read more
Global Cryotherapy Units Market by Manufacturers, Countries, Type and Application, Forecast to 2022

"Cryotherapy unit, also known as a cryotherapy chamber or cryosauna, is a medical device used for cryotherapy treatment. The basic principle of cryotherapy requires that the affected nerve is located and identified using imaging and visual techniques, followed by precise targeting using the built-in electrical stimulator in the cryotherapy unit.

Scope of the Report:
This report focuses on the Cryotherapy Units in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
JUKA
MECOTEC
Zimmer MedizinSysteme
Cryomed
KRION
Asperia Group
METRUM
HakoMed
Kriosystem Life
TIME
Titan Cryo
US Cryotherapy
CRYO Science
Impact Cryotherapy
Grand Cryo
Cryonic Medical
Kriomedpol
Cryo Manufacturing

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Liquid Nitrogen Therapy
Dry Ice Therapy
Electric

Market Segment by Applications, can be divided into
Local Cryo
Whole Body Cryo

Published

Read more
Global Closed System Transfer Device (CSTD) Market by Manufacturers, Countries, Type and Application, Forecast to 2022

"Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.

Scope of the Report:
This report focuses on the Closed System Transfer Device (CSTD) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
BD Medical, Inc
Equashield, LLC
ICU Medical, Inc
Teva Medical Ltd
Corvida Medical
Hospira

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into
Hospital
Clinic

Published

Read more
Global Helicobacter Pylori Testing Market by Manufacturers, Countries, Type and Application, Forecast to 2022

"This report studies the Helicobacter Pylori Testing market, Helicobacter pylori testing is used to diagnose an infection due to the bacteria and to evaluate the effectiveness of treatment.

Scope of the Report:
This report focuses on the Helicobacter Pylori Testing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health, Inc
Cardinal Health
Beckman Coulter Inc
Agilent Technologies
Coris BioConcept

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
With Endoscopy
Without Endoscopy

Market Segment by Applications, can be divided into
Physical examination center
Hospitals
Others

Published

Read more
Global Eye Anatomical Model Market by Manufacturers, Countries, Type and Application, Forecast to 2022

"Eye Anatomical Model is a kind of models to study and explain the internal and external structure of the eyes. Students interested in the medical profession as well as doctors, professors, and health care professionals profit from the realism of the models

Scope of the Report:
This report focuses on the Eye Anatomical Model in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
3B Scientific
SOMSO
GPI Anatomicals
Erler-Zimmer
Edutek Instrumentation
Sakamoto Model Corporation
Honglian Medical Tech
RUDIGER - ANATOMIE
Xincheng
Altay Scientific
Kanren
Denoyer-Geppert
Nasco
Educational + Scientific Products Ltd
Dynamic Tracom

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Small Size Eye Anatomical Model
Large Size Eye Anatomical Model

Market Segment by Applications, can be divided into
Education
Hospitals
Clinic
Others

Published

Read more
Global UV Infection Control Device Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"UV Light refers to Ultraviolet light which is outside the visible light spectrum between wavelength ranges of 100 nanometers (nm) to 400 nm. UV Light is classified into three wavelength ranges: UV-C from 100 nm - 280 nm, UV-B from 280 nm - 315 nm, UV-A from 315 nm - 400 nm.

Scope of the Report:
This report focuses on the UV Infection Control Device in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Getinge Group
STERIS
Clorox Professional
Xenex
Tru-D SmartUVC
Seal Shield
American Ultraviolet
UVC Cleaning Systems
Infection Prevention Technologies
AquiSense Technologies
Lumalier Corp
American Air & Waters

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Mobile Type
Stationary Type
Other Types

Market Segment by Applications, can be divided into
Hospital
Clinic
Others

Published

Read more
Global Titanium Dental Implants Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"A dental implant is a surgical component that interfaces with the bone of the jaw or skull to support a dental prosthesis such as a crown, bridge, denture, facial prosthesis or to act as an orthodontic anchor. The basis for modern dental implants is a biologic process called osseointegration, in which materials such as titanium form an intimate bond to bone. The implant fixture is first placed so that it is likely to osseointegrate, then a dental prosthetic is added. A variable amount of healing time is required for osseointegration before either the dental prosthetic (a tooth, bridge or denture) is attached to the implant or an abutment is placed which will hold a dental prosthetic.

Scope of the Report:
This report focuses on the Titanium Dental Implants in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Straumann
Danaher
Dentsply
Zimmer Biomet
Osstem
Henry Schein
GC
Kyocera Medical
Dyna Dental
Keystone Dental
Neobiotech
B & B Dental
Huaxi Dental Implant

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Endosteal Implants
Subperiosteal Implants
Other

Market Segment by Applications, can be divided into
Hospital
Dental Clinic

Published

Read more
Global Eye Anatomical Model Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Eye Anatomical Model is a kind of models to study and explain the internal and external structure of the eyes. Students interested in the medical profession as well as doctors, professors, and health care professionals profit from the realism of the models.

Scope of the Report:
This report focuses on the Eye Anatomical Model in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
3B Scientific
SOMSO
GPI Anatomicals
Erler-Zimmer
Edutek Instrumentation
Sakamoto Model Corporation
Honglian Medical Tech
RUDIGER - ANATOMIE
Xincheng
Altay Scientific
Kanren
Denoyer-Geppert
Nasco
Educational + Scientific Products Ltd
Dynamic Tracom

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Small Size Eye Anatomical Model
Large Size Eye Anatomical Model

Market Segment by Applications, can be divided into
Education
Hospitals
Clinic
Other

There are 15 Chapters to deeply display the global Eye Anatomical Model market.

Chapter 1, to describe Eye Anatomical Model Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Eye Anatomical Model, with sales, revenue, and price of Eye Anatomical Model, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Eye Anatomical Model, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Eye Anatomical Model market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Eye Anatomical Model sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source"

Published

Read more
Global FNIRS Brain Imaging System Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"Functional Near-infrared Spectroscopy (FNIRS) is a device designed to detect changes in the concentration of oxygenated (oxyHb) and deoxygenated (deoxyHb) haemoglobin molecules in the blood, a method commonly used to assess cerebral activity. fNIRS is a type of functional neuroimaging technology that offers a relatively non-invasive, safe, portable, and low-cost method of indirect and direct monitoring of brain activity.

Scope of the Report:
This report focuses on the fNIRS Brain Imaging System in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Hitachi
Shimadzu Corporation
NIRx
ISS
Biopac
Techen
Artinis
Gowerlabs
Spectratech

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Desk Type
Portable Type

Market Segment by Applications, can be divided into
University
Hospital
Research Institution
Others

There are 15 Chapters to deeply display the global fNIRS Brain Imaging System market.

Chapter 1, to describe fNIRS Brain Imaging System Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of fNIRS Brain Imaging System, with sales, revenue, and price of fNIRS Brain Imaging System, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of fNIRS Brain Imaging System, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, fNIRS Brain Imaging System market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe fNIRS Brain Imaging System sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source"

Published

Read more
Global Endoscopy Video Processors Market by Manufacturers, Countries, Type and Application, Forecast to 2023

"This report studies the endoscopy video processors market; endoscopy video processors are used for endoscopic images in HDTV or HD quality.

Scope of the Report:
This report focuses on the Endoscopy Video Processors in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Olympus
FUJIFILM
Stryker
KARL STORZ
HOYA
Richard Wolf
Boston Scientific
XION Medical
Tian Song
Shenda Endoscope
Sonoscape Company
Kanger Medical
HUGER
Mindray
AOHUA

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Video Processors without Display
Video Processors with Display

Market Segment by Applications, can be divided into
Upper GI Endoscopy
Colonoscopy
Bronchoscopy
Sigmoidoscopy
ENT Endoscopy
Others

There are 15 Chapters to deeply display the global Endoscopy Video Processors market.

Chapter 1, to describe Endoscopy Video Processors Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Endoscopy Video Processors, with sales, revenue, and price of Endoscopy Video Processors, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Endoscopy Video Processors, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Endoscopy Video Processors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Endoscopy Video Processors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source"

Published

Read more
Non-Invasive Prenatal Testing (NIPT) Market Analysis, Market Size, Test Analysis, Country Outlook, Growth Potential, Competitive Strategies and Forecasts, 2017 To 2021

"The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021.

Long–term Growth Projection:

More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021.

Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow at the CAGR of XX% during 2017-2021.

Market growth can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). With increased patient access to NIPT test, the NIPT test market is anticipated to have a positive outlook in the coming years. High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of NIPT test market.

NIPT Test Market: Test–wise Outlook

Natera Panorama test will lead the NIPT test market with the market share of more than 25% by the year end of 2021. MaterniT21 Plus and Bambini test have shown its potential to become 2nd and 3rd popular NIPT test. Harmony test is the fourth leading test in the NIPT test market. NIFTY and Verifi test hold the fifth and sixth highest share of the NIPT test market. Other emerging tests such as Prena, IONA, VisibiliT, Veracity and informaseq NIPT test which is likely to affect the market share during the forecast period.

NIPT Test Market: Country–wise Outlook:

United States is the most attractive market with market share of more than 50% in 2016. China will be the second largest market for NIPT test which is expected to grow at a CAGR of XX% by 2021. United Kingdom is expected to be third largest NIPT test market being followed by Germany by the end of the forecasted period.

This is the 3rd edition report on NIPT Test Market by DPI Research. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, country wise actual and potential market, NIPT test analysis with volume and market revenue and competitive landscape. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market

GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET SEGMENTATION

Global Non-Invasive Prenatal Testing (NIPT) Market – By Test Type

1. MaterniT21 PLUS
2. Harmony
3. NIFTY
4. Verifi
5. Panorama
6. PrenaTest
7. BambniTest
8. informaSeq
9. VisibiliT
10. Veracity
11. IONA Test

Global Non-Invasive Prenatal Testing (NIPT) Market – By Country

1. United States
2. United Kingdom
3. Germany
4. Italy
5. Spain
6. France
7. Switzerland
8. Sweden
9. Belgium
10. Australia
11. New Zealand
12. Japan
13. China
14. India
15. Brazil

"

Published

Read more
Neurostimulation Devices Market Insights, Opportunity, Analysis, Market Shares & Forecast 2016 – 2021

"The Global market for Neurostimulation Devices is expected to cross US$5 Billion by the year end of 2021.

Drivers & Restraints

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neurostimulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neurostimulation devices Market.

Segment Insights

Spinal cord stimulation segment dominated the neurostimulation devices market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation segment. It is expected that deep brain stimulation segment will grab nearly 20% market share by the year end of 2021.

Regional Insights

North America is seen as the dominant player in the neurostimulation devices market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neurostimulation devices market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neurostimulation.

Application Insights

Chronic Pain is identified as the largest application segment of the neurostimulation devices market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neurostimulation devices market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neurostimulation devices market.

Company Insights

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the neurostimulation devices market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, geographies, companies and market dynamics. The report concludes with the profiles of major players in the global neurostimulation market such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neurostimulation devices segment from 2010 to 2021. The report also entails major drivers and barriers of neurostimulation devices market.

Neurostimulation Devices Market: Segmentation

Neurostimulation Devices Market is classified on the basis of device segment, application, company and geography.

Based on Segment, Neurostimulation Devices Market can be segmented as follows:

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Other Devices Segment

Based on Application, Neurostimulation Devices Market can be segmented as follows:

• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Other Applications

Based on Geography, Neurostimulation Devices Market can be segmented as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)

Based on Company, Neurostimulation Devices Market can be segmented as follows:

• Medtronic
• Boston Scientific
• St Jude Medical
• Liva Nova(Cyberonics)
• Nevro
"

Published

Read more
China In Vitro Diagnostics(IVD) – Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021

"The in–vitro diagnostics(IVD) market in China has been growing rapidly in the past few years and is expected to grow steadily in the next few years, with major growth potential in segments such as infectious disease testing, chronic disease testing and diagnosis in early stages of disease. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories. However, low reimbursement rate, absence of quality products by the local companies, population factors and foreign companies faces difficulty to enter the low end IVD products market are restraining the growth of this market.

Long–term Outlook: The China In Vitro Diagnostics Market is expected to reach more than US$ 10 Billion by 2021 with strong double digit growth rate from 2016 to 2021.

China IVD Market: Segment wise Outlook

Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market.

China IVD Market: Companies wise Outlook

Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering(KHB) are another major participant in this market with a good hold in clinical chemistry, immunoassay and molecular testing segments providing varieties of reagents nationwide and semi–auto and automatic biochemistry analyzers to low and mid–end market users.


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market, market segments, company wise sales analysis, regulation, major distributors and laboratories of IVD and outlook of the Chinese IVD companies.

This report titled “China In Vitro Diagnostics(IVD) – Opportunity Assessment, Competitive Landscape and Market Forecasts to 2021” has been analyzed from 10 viewpoints:

1. Market and Forecast (2010 – 2021)
2. Segment Wise Market and Forecast (2010 – 2021)
3. Company Wise IVD Sales and Forecast (2010 – 2021)
4. Regulation and its Latest Development
5. Future Prospects in Attractive In Vitro Diagnostics Segments
6. Regional Trends and Opportunities
7. Main Participants/Contributors
8. Major IVD Product Companies Outlook
9. Major Private Clinical Labs and Diagnostic Services Companies Outlook
10. Market Growth Drivers and Challenges

The following segments of the China In Vitro Diagnostics market are detailed with size and six year forecast.


Ø Clinical Chemistry
Ø Immunoassay
Ø Molecular Testing
Ø Self–Monitoring of Blood Glucose (SMBG)
Ø Point of Care Testing (POCT)
Ø Hematology
Ø Coagulation
Ø Microbiology


The following companies of the China In Vitro Diagnostics market are detailed with size and six year forecast


Ø Roche Diagnostics
Ø Abbott Laboratories
Ø Mindray Medical International Limited
Ø Sysmex Corporation
Ø Shanghai Kehua Bio–Engineering Co. Ltd.
Ø Other Companies

The following Chinese companies of the China In Vitro Diagnostics market are detailed with company overview and its product portfolio


Ø Mindray Medical International Limited
Ø Shanghai Fosun Pharmaceutical Group
Ø Mingyuan Medicare
Ø Da An Gene Co. Ltd.
Ø Shanghai Kehua Bio–Engineering Co. Ltd.
Ø Zhejiang D.a. Diagnostics Technology Co., Ltd
Ø ADICON Clinical Laboratories
Ø Guangzhou Kingmed Diagnostics Center Co. Ltd.
Ø Kindstar Global
Ø BGI – Shenzhen
Ø OriGene Technologies
"

Published

Read more
Global Hip Replacement Implants Market 2016: Market Size, Analysis, Share, Competitive, Growth & Forecast 2021Size

"Hip Replacement Implants Market: Overview

The global market overview for hip replacement implants looks promising considering advances in computer–assisted total hip replacement as well as the other technological platforms. The hip replacement implants market will continue to grow due to an aging population in much of the world. Increasing life spans and lifestyles impact the number of individuals with joints subject to failure, thereby increasing demand for hip replacement procedures. Additionally, the growing health awareness among masses, along with increase in the spending capacity of the population are propelling the market growth.
Global hip replacement implants market is projected to reach more than US$ 5 Billion by 2021, at a CAGR of XX% from 2016 to 2021.
Hip Replacement Implants Market: Country–wise Outlook
United States holds the highest share with more than 50% in 2015, and is expected that United States will maintain its position in the forecasting period. Japan and China hold the 2nd, and 3rd position in the hip replacement implants market. However, some of the European countries hip replacement implants market dwindle due to the EU austerity measures and the cutbacks in reimbursement have led to a decline over the past few years, while procedure numbers have still continued to grow in a modest way.
Hip Replacement Implants Market: Key Players Outlook
The global hip replacement market is dominated by Zimmer Biomet, Stryker, DePuy Synthes and Smith & Nephew. The three large players in the hip replacement implants market are Zimmer Biomet, DePuy Synthes and Stryker combined, they comprise almost more than 80% of the market. Other nominal yet important players of this market include Wright Medical, Exactech, DJO Global and many more. It is expected that Zimmer Biomet will emerge as a leading company in the hip replacement implants market in the forecasting period. The opportunity is immense in the emerging markets, as there is a large untapped population with the surgical need of hip implants.


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. The report concludes with the profiles of major players in the global hip replacement implants market such as Zimmer Biomet, Stryker, Smith & Nephew, Exactech, DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of hip replacement implants from 2008 to 2021.

The report covers in–depth analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2008 – 2015
• Market Size & Forecast 2016 to 2021
• Competition & Companies involved
• Deals Landscapes
• Market Growth Drivers and Challenges

Global Hip Implants Market is segmented as follows:

• Global – Hip Replacement Implants Market & Forecast (2008 – 2021)

• Global – Hip Replacement Implants Market Share & Forecast (2008 – 2021)

o Top 5 Company Market Share Outlook
o Top 10 Country Market Share Outlook

• Global Replacement Hip Implants Market – Top 10 Country Outlook

o United States
o Germany
o Italy
o France
o Spain
o United Kingdom
o Japan
o Brazil
o China
o India

• Global – Hip Replacement Implants Market: Key Company Analysis

o Zimmer Biomet
o Stryker
o DePuy Synthes (Johnson & Johnson)
o Smith & Nephew
o Exactech
o Other Companies

• Global Hip Replacement Implants Market: Deals Landscape

o Merger & Acquisitions
o Partnerships
o Collaboration
o Distribution Agreement

• Global Hip Replacement Implants Market: Growth & Challenges
"

Published

Read more
Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021

"Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing.

The global molecular diagnostics market is projected to reach more than US$ 30 Billion by 2021, at a CAGR of XX% from 2016 to 2021.The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market

North America dominates the global market of molecular diagnostics due to increasing incidence of infectious diseases and lifestyle associated diseases. North America controls more than 40% of the market share by the year 2021. Japan, China and India is expected to show high growth rates in the next six years in molecular diagnostics market.

On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment. Oncology test controls nearly 25% market share by the year 2021.
Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market.

In terms of technology, Biochips/Microarrays is the fastest growing segment and is expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years.

On the basis of company, Roche is the leading company with more than 30% market share in the global molecular diagnostics market and is expected to hold its strong position in the market. Becton Dickinson, Myriad Genetics, Abbott and Qiagen is expected to robust market growth in the global molecular diagnostics market.
The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically–supported and industry–validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics Sales & Forecast 6) Market Growth Drivers & Challenges


Global Molecular Diagnostics Market has been analyzed from 6 viewpoints:

1) Market and Forecast
2) Application Wise Market & Forecast
3) Geographical Market & Forecast
4) Technology Wise Market & Forecast
5) Company Wise Molecular Diagnostics sales & Forecast
6) Market Growth Drivers & Challenges


The following application segments of the molecular diagnostics market are detailed with size and six year forecast.

• Infectious Disease Testing
• Cardiovascular Disease Testing
• Oncology Testing
• Neurological Disorders Testing
• Food Pathogen Detection Testing
• Genetic Testing
• Blood Screening
• Tissue Typing (HLA Testing)
• Others Molecular Testing


Furthermore, the following technology segments of the molecular diagnostics market are detailed with size and six year forecast.

• PCR Based Test
• PCR Related Technologies
• Non–PCR Test
• Fish & Innovations Testing
• Biochips/Microarrays
• Biosensors
• Molecular Imaging
• Other Technologies

The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include:

• North America
• Europe
• Japan
• China
• India
• Brazil
• Mexico
• Korea
• Rest of the world

The following companies of the molecular diagnostics market are detailed with size and six year forecast.

• Roche
• Abbott Laboratories
• Myriad Genetics
• Qiagen
• Cephied
• Becton Dickinson
• Biomerieux
• Other Companies

Research You Can Trust:

This reports are written by our research team, a dedicated group of analysts that knows the industry inside and out.

Data Sources

The information contained in this report is based on secondary sources.

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. Research team seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, newspapers, books, Government official websites and other paid database sources.
"

Published

Read more
High Intensity Focused Ultrasound(HIFU) by Company Profile, Deals Type, Key Trends & Opportunities to 2022

"High–Intensity Focused Ultrasound (HIFU) is a highly precise medical procedure that applies high–intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue through ablation. HIFU is one modality of therapeutic ultrasound, involving minimally invasive or non–invasive methods to direct acoustic energy into the body. In HIFU therapy, ultrasound beams are focused on diseased tissue, and due to the significant energy deposition at the focus, temperature within the tissue can rise to levels from 65° to 85°C, destroying the diseased tissue by coagulation necrosis.

Recent advances in HIFU, which was developed in the 1940s as a viable thermal tissue ablation approach, have increased its popularity. In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well–defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft–tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio– and chemo–therapy, HIFU has the advantages of non–invasion, non–ionization, and fewer complications after treatment. More than 115, 000 cases have been treated throughout the world with great success till 2015.

High prevalence of cardiovascular diseases and cancer cases, rapidly growing aging population, rising number of new product launches, growing number of clinical studies regarding the applications of HIFU, and increasing focus of key players on the development of technologically advanced systems are the key factors driving the market growth. Moreover, emerging applications such as gynecology & obstetrics, neurosurgery, urinary disorders imaging, and removal of excess subcutaneous fatty tissue using high–energy sound waves would further propel the growth of the high–intensity focused ultrasound market in the coming six years. However, the stringent government regulations for the approval of HIFU system, rising price pressure faced by market players and unfavorable of reimbursement scenario are the key factors restraining the growth of this market.

The Research report presents a comprehensive assessment of the HIFU manufacturers, research sites, pre–clinical research sites, clinical research sites, commercial treatment sites, treatment by indication. The report also brings together major distribution agreement, collaboration deals and partnership deals information in the HIFU market. Furthermore, each company have been profiled on the basis of various attributes such as company overview, HIFU products, latest developments, growth strategies and financial revenue.


The following 10 companies of the High Intensity Focused Ultrasound market are detailed with:

• Company Overview
• HIFU Products
• Companies HIFU Revenue
• Latest Development in High Intensity Focus Ultrasound (HIFU) Market


High Intensity Focused Ultrasound(HIFU) – 10 Companies covered

1) EDAP TMS
2) Sonacare Medical
3) Haifu Medical
4) Shanghai A&S Co., LTD
5) Mianyang Sonic Electronic Ltd.
6) Insightec
7) Theraclion
8) Alpinion Medical Systems
9) FUS Instruments
10) Image Guided Therapy


Research You Can Trust:

This reports are written by our research team, a dedicated group of analysts that knows the industry inside and out.

Data Sources

The information contained in this report is based on secondary sources.

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. Research team seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, newspapers, books, Government official websites and other paid database sources.
"

Published

Read more
Point of Care Testing – Global Analysis & Market Forecasts

"Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which offer a closer connection to the patient. The dynamic of point of–care testing (POCT) is to bring testing closer to the patient and results conveniently and quickly to the provider to expedite diagnosis and subsequent treatment. POCT allows for faster clinical decisions in hospitals, physicians’ offices, ambulances, patient homes, and in the field.

The global point of care testing market is projected to reach US$ 38 Billion by 2022, at a CAGR of XX% from 2016 to 2022. The global market is mainly driven by increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home–based POC devices, and technological advancements with regard to development of advanced, faster, and easy to–use devices are stimulating the demand for POCT

This report titled “Point of Care Testing – Global Analysis & Market Forecasts” provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals and collaboration deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.

The following 13 segments of the point of care testing market are detailed with market size and six year forecast.

• Blood Glucose Testing
• Cardiac Markers Testing
• Lipid Panel/Cholesterol Testing
• Blood Coagulation Testing
• Infectious Disease Testing
• Urinalysis Testing
• Drug of Abuse Testing
• Pregnancy & Fertility Testing
• Cancer Markers Testing
• Critical Care Testing
• HbA1C Testing
• Clinical Chemistry Testing
• Bilirubin Testing


This report also gives access to significant data such as:

• Market Growth Drivers in the Point of Care Testing Market
• Challenges in the Point of Care Testing Market
• Current Market Trends
• Market Forecasting for the Coming Years
• Merger & Acquisitions between major companies
• Distribution Agreement
• Licensing Deals
• Collaboration Deals
"

Published

Read more
Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) - Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 – 2021

"Non-Invasive Prenatal Test (NIPT) are targeted at the detection of certain specific chromosomal aneuploidies from maternal blood sample in pregnant women at high risk for fetal aneuploidies. Currently, the prenatal testing market is experiencing a paradigm shift from conventional prenatal screening and diagnostic methods to non-invasive prenatal testing. This is mainly because of the advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for common chromosomal abnormalities.

NIPT is one of the most promising new areas of screening because it delivers highly actionable insights for empowering critical health decisions. The global non-invasive prenatal testing market is segmented on the basis of tests viz; Harmony, MaterniT21 PLUS, PrenaTest, Verifi, BambniTest, Panorama, InformaSeq, Non-Invasive Fetal Trisomy Test (NIFTY), VisibiliT, Veracity and IONA Test. NIPT has experienced substantial growth over the past few years.

MaterniT21 plus test has gain its momentum in 2011 when there was only one NIPT test available in the market. In 2015, The MaterniT21 plus test market revenue decreased with XXX% compared to 2014. MaterniT21 test market revenue value was US$ XXX Million in 2015. Natera has emerged as one of the leading companies, with innovative technologies and a strong commercial base. Natera Panorama test will lead the NIPT market in the forecasting period with the market share of XXX% by the year 2021. Other NIPT tests such as Harmony, Verifi and NIFTY have emerged as the promising test in the NIPT test market. The major companies are expanding their tests through Collaboration, Distribution Agreement, Strategic Alliances and Partnerships with Clinical Laboratories and Hospitals.

DPI Research report titled Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) - Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 – 2021. The report presents a comprehensive study of the Global NIPT market with market revenue and volume of the tests. market shares for leading NIPT test, comparative analysis of the non–invasive prenatal testing, NIPT implementation in HICs and LMICs, major deals in the NIPT market such as Collaborations, Partnerships, Distribution Agreement, Venture Capital Investment, Merger & Acquisition, Licensing Agreement and Exclusive Agreement. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market

Key segments of the Global NIPT market

The 11 NIPT Test covered in the report has been analyzed from 2 viewpoints:

1. NIPT Test Market Revenue (2011 - 2021)
2. NIPT Test Volume (2011 - 2021)

The following are the NIPT test name which is covered in the report.

1) BambniTest
2) Harmony
3) informaSeq
4) MaterniT21 PLUS
5) NIFTY
6) Panorama
7) PrenaTest
8) verifi
9) VisibiliT
10) Veracity
11) IONA Test

The report also covers NIPT implementation in High Income Countries and Low - or- Middle Income Countries. The 3 issues for implementation covered are:

1) Clinical Issues
2) Ethical Issues
3) Legal and Regulatory Issues


This report gives access to significant data such as:

• Market Growth Drivers
• Challenges in the NIPT Test Market
• Current Market Trends
• Market Forecasting for the Coming Years
• Comparative Test Analysis

Data Sources

The information contained in this report is based on both primary and secondary sources.

Primary Sources: Questionnaires, Surveys, telephonic interviews with industry experts and Observations

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.
"

Published

Read more
United States and Japan Proton Therapy Market Analysis2012 to 2017 and Forecast 2018 to 2025

"“United States and Japan Proton Therapy Market Analysis2012 to 2017 and Forecast 2018 to 2025”presents an in-depth assessment of the proton therapymarket dynamics,opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for proton therapy in United States and Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.

A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies. The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US and Japan proton therapy centers. The report also includes assessment of US and Japan reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the US and Japan proton therapy market.

The report concludes with the profiles of major players in the US and Japan proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies, recent development of the proton therapy market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Hitachi, Optivus, Ion Beam Applications(IBA), Varian Medical Systems, Mevion Medical Systems, Mitsubishi Electric, Sumitomo Heavy Industries Ltd.

Key Findings:

• United States proton therapy marketwill exhibit growth by a CAGR of over 15% up to 2025
• The potential United States and Japan proton therapy market is set to cross USD 10 Billion by 2025
• In 2017, IBA accounted highest number of proton therapy centers in United States
• Hitachi has the second highest number of treatment rooms in United States and Japan
• Hitachi and Mitsubishi Electric Merged Proton Therapy System Business

This independent 160-page report has been analysed from 15 viewpoints:

• United States and Japan Proton Therapy Market Size & Analysis(2012 – 2025)
• United States and Japan Proton Therapy Market Opportunity Assessment(2012 – 2025)
• United States and Japan Number of Treatment Rooms and Forecast (2012 – 2025)
• United States and Japan Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• United States and Japan Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• Major Deals in Proton Therapy Market
• United States and Japan Number of Patients Treated at Proton Therapy Center
• United States and Japan Proton Therapy Reimbursement Scenario
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Key Market Drivers and Inhibitors
• Major Companies Analysis
"

Published

Read more
United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 – 2025

"“United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 - 2025”presents an in-depth assessment of the proton therapymarket dynamics,opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for Proton Therapy in United States. The research includes historic data from 2012 to 2017 and forecasts until 2025.

Long–term Growth Projection:

• United States proton therapy marketwill exhibit growth by a CAGR of over 15% up to 2025
• United States is anticipated to be the most attractive market in the proton therapy market industry
• The potential United States proton therapy market is set to cross USD 7 Billion by 2025
• In 2017, IBA accounted highest number of proton therapy centers in United States
• Hitachi has the second highest number of treatment rooms in United States

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.

The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers.

The report also includes assessment of US reimbursement scenario, proton therapy clinical trialsand offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensingand development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market.

The report concludes with the profiles of major players in the USproton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio,US proton therapy centers developed by the companies, recent development & trends of the proton therapy market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Hitachi,Optivus, Ion Beam Applications(IBA), Varian Medical Systems, Mevion Medical Systems

The Latest Industry Data Included in this Report:

• Proton Therapy Market Size & Analysis(2012 – 2025)
• Proton Therapy Market Opportunity Assessment(2012 – 2025)
• Number of Treatment Rooms and Forecast (2012 – 2025)
• Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• Major Deals in Proton Therapy Market
• Number of Patients Treated at Proton Therapy Center
• Proton Therapy Reimbursement Scenario
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Key Market Drivers and Inhibitors
• Major Companies Analysis
"

Published

Read more
United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023

"The report titled “United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023” examines the market dynamics, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for NIPT test in United States. The research includes historic data from 2015 to 2017 and forecasts until 2023.

Long–term Growth Projection:

• United States is anticipated to be the most attractive market in the Non-Invasive Prenatal Testing(NIPT) industry
• United States Non-Invasive Prenatal Testing(NIPT) is expected to register a faster value growth during 2018 - 2023
• The Potential United States Non-Invasive Prenatal Testing(NIPT) Market is set to cross USD 2.5 Billion by 2023
• MaterniT21 PLUS, Harmony, Verifi, Panorama are the popular test in the United States Non-Invasive Prenatal Testing(NIPT) Market

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2023. The report also includes assessment of comparative test analysis by companies.It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT test market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.

The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT

test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Illumina, Natera, Quest Diagnostics, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche)

Major and Promising NIPT test covered in the report are as follows:

MaterniT21 PLUS, VisibiliT, MaterniT21 GENOME,Harmony, Verifi, Panorama,Vistara andQNatal Advanced

The Latest Industry Data Included in this Report:

• Actual NIPT Test Volume& Market Revenue (2015 - 2023)
• Average Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• High Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• Potential NIPT Test Volume& Market Revenue (2015 - 2023)
• Average Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• High Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• NIPT Test Market - Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• Comparative Test Analysis – By Companies
• Major Deals in Non–Invasive Prenatal Testing Market
• Key Companies Analysis
• Key Market Drivers and Inhibitors of the United States NIPT Test Market
"

Published

Read more
Japan Proton Therapy Market Research Report 2018

"The report titled “Japan Proton Therapy Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.

Long–term Growth Projection:

• Hitachi and Mitsubishi Electric Agree to Integrate Proton Therapy System Business
• Japan is anticipated to be the most attractive market in the proton therapyindustry.
• The potential Japan proton therapy market is likely to reach more than USD 3 Billion by 2025
• Mitsubishi Electric is a technology leader in the field of proton therapy in Japan.
• Hitachi has thesecond highest share in the treatment rooms segment.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of Japan proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.

The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at Japan proton therapy centers from 2008 to 2016.

The report also includes assessment of Japan reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Japan proton therapy market.


The report concludes with the profiles of major players in the Japan proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, Japan proton therapy centers developed by the companies and recent development & trends of the proton therapy market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Mitsubishi Electric,Hitachi, Sumitomo Heavy Industries Ltd. and Ion Beam Applications(IBA)

The Latest Industry Data Included in this Report:

• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Market Size & Analysis: Japan Proton Therapy (2012 – 2025)
• Market Opportunity Assessment: Japan Proton Therapy (2012 – 2025)
• Japan Number of Treatment Rooms and Forecast (2012 – 2025)
• Japan Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
•Japan Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy
Accelerator
• Japan Number of Patients Treated at Proton Therapy Centers (2008 – 2016)
• Japan Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Proton Therapy Market – Major Deals
• Key Market Drivers and Inhibitors of the Japan Proton Therapy Market
• Major Companies Analysis
"

Published

Read more
Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 - 2017) and Future Forecast (2018 - 2025)

"Insulin Delivery Pen Market is expected to exceed US$ 14 Billion across the ten major markets (10MM) by 2025.

The report “Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 - 2017) and Future Forecast (2018 - 2025)” offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM). The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.

Key Findings:

• Germany accounted for 15% of the insulin delivery pen market in 2017
• China dominates the reusable insulin delivery pen market
• Reusable insulin delivery pen has the highest volume share in the overall insulin delivery pen market
• Disposable insulin delivery pen is expected to register a faster value growth during 2018-2025
• Japan is the third largest insulin delivery pen market
• Flexpen, Solostar and KwikPen are the leading brand in the insulin delivery pen sector

The Latest Industry Data Included in this Report:

• Diabetes Population in 10 major market(10MM) 2011-2025
• Insulin Users Insights in 10 major market(10MM) 2011-2025
• Overall Insulin Delivery Pen Users, 2011-2025
• Overall Insulin Delivery Pen Market Size, 2011-2025
• Insulin Delivery Pen Market Size by Product Segments, 2011-2025
• Growth Rates of the Overall Market and Different Product Segments, 2011-2025
• Shares of Different Product Segments of the Overall Market, 2011- 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Recent Development

The Report Facilitates Answer the Subsequent Questions:

• What is the size of the insulin delivery pen market in 10 major market(10MM)?
• How much reusable and disposable pen users in 10 major market(10MM)?
• How is the insulin delivery pen market divided into two different types of segments?
• How are the overall market and segments types growing?
• How is the market predicted to develop in the future?
• Who are the market players?
"

Published

Read more
United States Insulin Delivery Devices Market Outlook 2017: Key Product Categories (Insulin Pumps, Insulin Pens (Reusable, Disposable) Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

"United States Insulin Delivery Devices Market is anticipated to surpass US$ 6 Billion by 2022.

Growth in US insulin delivery devices market can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, user–friendly design, help avoid over/under–dosing of insulin, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin delivery devices.

The report titled “United States Insulin Delivery Devices Market Outlook 2017: Key Product Categories (Insulin Pumps, Insulin Pens (Reusable, Disposable) Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States insulin pump and insulin pen market.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2022. A comprehensive analysis has been done on market share of insulin delivery devices segment.

The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population in United States. It provides essential insights into total insulin delivery users, insulin pump users and insulin pen users with more focused–on reusable and prefilled insulin pen users.

The report further sheds light on detailed US reimbursement scenario of insulin pump and insulin pen. Additionally, the report includes assessment of preferred insulin pump brand by the patients. The report also explores detailed description of growth drivers and inhibitors of the United States insulin delivery market.

The report concludes with the profiles of major players in the insulin delivery devices market such as Insulet Corporation, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product portfolios and latest development and trends of the insulin delivery devices market.


Key Highlights of the United States Insulin Delivery Devices Market Report:

• Diabetes Population (2011 – 2022)
• Overall Insulin Delivery Users Snapshot (2011 – 2022)
• Insulin Pump Users (2011 – 2022)
• Type 1 Diabetes Insulin Pump Users (2011 – 2022)
• Type 2 Diabetes Insulin Pump Users (2011 – 2022)
• Insulin Pen Users (2011 – 2022)
• Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
• Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
• Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share (2011 – 2022)
• Overall Insulin Delivery Devices: Market Snapshot (2011 – 2022)
• Insulin Pump Market Size (2011 – 2022)
• Insulin Pen Market Size (2011 – 2022)
• Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
• Prefilled (Disposable) Insulin Pen Market (2011 – 2022)
• Insulin Delivery Devices Segment (Insulin Pump & Insulin Pen) Market Share (2011 – 2022)
• Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share (2011 – 2022)
• Insulin Pump Preferred Brand – By Product (2011 – 2022)
• Insulin Pump and Pen Reimbursement Scenario (2011 – 2022)
• Key Drivers and Inhibitors of the Insulin Delivery Devices Market
• Key Companies Analysis

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

• Insulet Corporation
• Medtronic
• Roche
• Tandem Diabetes Care
• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford

Key Deliverables in the Study

• Market Definition for the specified topic along with identification of key drivers and inhibitors for the market

• Trending factors influencing the market shares of the United States Insulin Delivery Devices

• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

• It provides a five-year forecast which helps to provide a long-term assessment of developments in the United States Insulin Delivery Devices Market.

• Identification and Analysis of the Macro and Micro factors that affect the United States Insulin Delivery Devices Market

• Identification of factors instrumental in changing the market scenarios, rising prospective opportunities

• A comprehensive list of key market players along with the analysis of their current product portfolios and recent development
"

Published

Read more
United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025

"United States Proton Therapy market is expected to reach nearly US$ 1 Billion, potentially US$ 7 Billion by 2025.

Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers, decreasing cost of proton therapy treatment, technological advances and market adoption. However, high costs involved in the establishment of the center is likely to restrain growth in the forecast period.

The research report titled “United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 - 2025” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States actual and potential proton therapy market.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.

The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers from 2008 to 2015.

The report also includes assessment of US reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market.

The report concludes with the profiles of major players in the US proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies and recent development & trends of the proton therapy market.

Key Highlights of the United States Proton Therapy Market Report:

• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Market Size & Analysis: United States Proton Therapy (2012 – 2025)
• Market Opportunity Assessment: United States Proton Therapy (2012 – 2025)
• United States Number of Treatment Rooms and Forecast (2012 – 2025)
• United States Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• United States Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• United States Number of Patients Treated at Proton Therapy Centers (2008 – 2015)
• United States Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Proton Therapy Market – Major Deals
• Key Market Drivers and Inhibitors of the United States Proton Therapy Market
• Major Companies Analysis

Key Companies Covered in the Report are as follows:

• Optivus
• Hitachi
• Ion Beam Applications(IBA)
• Varian Medical Systems
• Mevion Medical Systems"

Published

Read more
Diabetes Disposable Insulin Pen Market by Country (Germany, United Kingdom, France, Italy, Spain) Analysis, Growth Potential & Demand Forecast 2017 – 2022

  1. Disposable Insulin Pen Market is anticipated to surpass US$ 4 Billion across the top 5 European countriesof the France, Germany, Italy, Spain and United Kingdom by 2022.

    “Diabetes Disposable Insulin Pen Market by Country (Germany, United Kingdom, France, Italy, Spain) Analysis, Growth Potential & Demand Forecast 2017 – 2022” report provides comprehensive understanding and unprecedented access to the Diabetes Disposable Insulin Pen Industry entered by the world leading healthcare companies.

    The research report examines the market, demand, competitive landscape and trends of the top 5 European markets of the diabetes disposable insulin pen market. It provides an all-round analysis of overall number of patients with diabetes and insulin users. It offers information on users of insulin pens, specifically focusing on prefilled(disposable) insulin pen users. Annual estimates and forecasts are provided for the period 2017 through 2024. Also, a five-year historic analysis is provided for these markets. The report also explores detailed description of growth drivers and barriers of the diabetes disposable insulin pen market.

    The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly and Sanofi. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the diabetes disposable insulin pen market.

    Top 5 European Countries Covered in the Report Have Studied from 4 Viewpoints:

    1. Overall Diabetes Population (2011 – 2022)
    2. Insulin Users (2011 – 2022)
    3. Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
    4. Prefilled (Disposable) Insulin Pen Market (2011 – 2022)

    Top 5 European Countries Covered in the Report are as follows:

    1. United Kingdom
    2. France
    3. Italy
    4. Spain
    5. Germany

    Key Companies Covered in the Report are as follows:

    1. Novo Nordisk
    2. Eli Lilly and Company
    3. Sanofi

Published

Read more
High Intensity Focused Ultrasound System Industry Insights, Trends, Outlook and Competitive Landscape To 2022

"High Intensity Focused Ultrasound System Industry Insights, Trends, Outlook and Competitive Landscape To 2022” report provides comprehensive understanding and unprecedented access to the High Intensity Focused Ultrasound System Industry entered by the world leading healthcare companies.

The Research report presents a comprehensive assessment of the HIFU research sites, pre–clinical research sites, clinical research sites, technical research sites, commercial treatment sites and treatment by indication. Additionally, the report includes assessment of clinical trials and reimbursement pattern of the HIFU System. Key trends in terms of collaborations, distribution agreement and partnership deals are analysed with details.

The report concludes with the profiles of major players in the HIFU System Industry. The key market players are evaluated on various parameters such as business overview, product portfolios, growth strategies, financial revenue and recent development & trends.

Key Findings of the Report:

• Profound Medical Corporation acquired Royal Philips Sonalleve MR-HIFU Business
• Europe has the highest number of HIFU Research Sites
• There are more than 100 HIFU Pre–Clinical Research Sites in the world
• EDAP TMS will generate more than US$ XX Million HIFU revenue by 2022
• EDAP TMS partners with Vituro Health
• SonaCare Medical granted FDA regulatory clearance for updated HIFU Prostate Tissue Ablation Device
• Insightec HIFU revenue is likely to reach more than USD XX Million by 2022
• Siemens and Insightec sign agreement to expand access to exablate neuro technology
• Theraclion HIFU revenue is likely to increase more than US$ XX Million by 2022
• Theraclion announces first patients treated in US pivotal multicentre FDA study
• Eye Tech Care announced USD 25 Million funding and partnership agreement with Everpine Capital

High Intensity Focused Ultrasound(HIFU) System Company Analysis - 23 Companies Covered

1) EDAP TMS
2) Sonacare Medical
3) Haifu Medical
4) Shanghai A&S Co., LTD
5) Insightec
6) Theraclion
7) Alpinion Medical Systems
8) FUS Instruments
9) Image Guided Therapy
10) Medsonic Ltd
11) Promedica Bioelectronics
12) Sumo Corporation Ltd
13) Mirabilis Medica
14) Eye Tech Care
15) Profound Medical Corp
16) Shenzhen Wikkon
17) Shenzhen PRO-HIFU Medical Tech. Co., Ltd
18) Verasonics
19) EpiSonica
20) Car Thera
21) Histosonics, Inc
22) Navifus
23) Toosonix
"

Published

Read more
Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017-2022

"Diabetes Insulin Pen Market is anticipated to surpass US$ 5 Billion across the top 5 European countries of the France, Germany, Italy, Spain and United Kingdom by 2022.

Long–term Growth Projection and Development:

• Prefilled(Disposable) insulin pen grasps the dominant share in the top 5 European countries insulin pen market
• In 2016, there were over 7,800 Thousand users of insulin pen in the top 5 European countries
• Germany insulin pen market generated more than US$ 1.5 Billion in 2016
• Spain has shown its potential to become leading #2 market with around 20% market share in 2016

Market growth can be attributed to factors such as increasing number of patients with diabetes, high adoption rate, user–friendly design, surging popularity amid consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices.

The research report titled “Diabetes Insulin Pen Market Outlook 2022: Top 5 European Countries Opportunity and Demand Analysis, Market Forecast 2017-2022” examines the market, demand, competitive landscape and trends of the top 5 European markets of the insulin pen market. It provides an all-round analysis of overall number of patients with diabetes and insulin users. It offers information on users of insulin pens, specifically focusing on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for insulin pen market has been detailed in the report. The report also explores detailed description of growth drivers and barriers of the insulin pen market.

The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford and Ypsomed. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market.

Top 5 European Countries Covered in the Report Have Studied from 8 Viewpoints

1. Overall Diabetes Population (2011 – 2022)
2. Insulin Users (2011 – 2022)
3. Insulin Pen Users (2011 – 2022)
4. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
5. Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
6. Insulin Pen Market (2011 – 2022)
7. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
8. Prefilled (Disposable) Insulin Pen Market (2011 – 2022)

Top 5 European Countries Covered in the Report are as follows:

1. United Kingdom
2. France
3. Italy
4. Spain
5. Germany

Key Companies Covered in the Report are as follows:

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford
5. Ypsomed
"

Published

Read more
Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024

"China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.

Long–term Growth Projection and Development:

• It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
• More than 3,00,000 NIFTY tests done in 2016
• Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
• Two–Child policy is likely to boost China NIPT market

Growth in China NIPT market can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of China NIPT market. Due to expanding patient access to NIPT test, the China NIPT test market is poised to have a positive outlook in the year ahead.

The research report titled “Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the China actual and potential NIPT market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues; and provides forecasts through 2024. It also includes a snapshot of the NIPT implementation in the low and middle-income countries. The report also explores detailed description of growth drivers and inhibitors of the China NIPT Market.

The report concludes with the profiles of major players in the China NIPT Market. The key market players are evaluated on various parameters such as company introduction, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development/updates of the NIPT Market in China.

Key Topics Covered in the Report

• 2013 - 2024: China Potential NIPT Test Market Size & Analysis (Volume and Value)
• 2013 - 2024: China Actual NIPT Test Market Size & Analysis (Volume and Value)
• NIPT Test Implementation in Low & Middle–Income Countries
• Key Companies Analysis
• Key Drivers and Inhibitors of the China NIPT Test Market

Key Companies Covered in the Report are as follows:

• Berry Genomics
• BGI Diagnosis Co., Ltd
• Basetra
"

Published

Read more
Mammography Screening Market Outlook 2022: United States Opportunity and Demand Analysis, Market Forecast 2017 - 2022

"United States mammography screening market is expected to reach more than US$ 5.4 Billion by 2022. Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in mammography technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.

“Mammography Screening Market Outlook 2022: United States Opportunity and Demand Analysis, Market Forecast 2017-2022” provides a deep and thorough evaluation of the United States mammography screening market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.

Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. Additionally, the report includes assessment of breast cancer clinical trials and mammography reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States mammography screening market.

The report concludes with the profiles of major manufacturers of mammography system such as Hologic, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on parameters such as business overview and mammography marketed products.

Key Topics Covered in the Report

• United States Breast Cancer Cases (2010 - 2022)
• United States Breast Cancer Mammography Screening Population (2010 – 2022)
• United States Breast Cancer Death (2010 – 2017)
• Market Overview: United States Mammography Screening (2010 – 2022)
• Reimbursement Policies of the United States Breast Cancer Screening
• Breast Cancer Screening Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the United States Mammography Screening Market
• Key Manufacturers Analysis

Major Companies Covered in this Report:

• Hologic
• Siemen Healthineers
• Philips Healthcare
• GE Healthcare
• Toshiba Medical Systems Corporation
"

Published

Read more
United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022

"United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022.

Long–term Growth Projection:

• Mammography grasp the dominant share in the United States Breast Cancer Screening Market
• Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
• Number of mammograpy screening population in United States will increase to more than 50 Million by 2022

Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.

“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.

Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.


The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products and latest development and trends

Key Topics Covered in the Report

• United States Breast Cancer Cases (2010 - 2022)
• United States Breast Cancer Mammography Screening Population (2010 – 2022)
• United States Breast Cancer Death (2010 – 2017)
• Market Overview: United States Breast Cancer Screening (2010 – 2022)
• Market Share: United States Breast Cancer Screening (2010 – 2022)
• By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
• Reimbursement Policies of the United States Breast Cancer Screening
• Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
• Key Manufacturers Analysis


Major Breast Cancer Screening Analyzed Under This Report Are:

• Mammography
• Breast Magnetic Resonance Imaging(MRI)
• Breast Ultrasound

Major Companies Covered in This Report:

• Hitachi Medical Corporation
• Siemen Healthineers
• Philips Healthcare
• Toshiba Medical Systems Corporation
• GE Healthcare
• Hologic
"

Published

Read more
North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022

"North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022.

Long–term Growth Projection:

• Number of diabetes population in United States will increase to more than 33 Million by the year end of 2022

• In 2016, there were more than 5,00,000 insulin pump users in United States

• Canada Insulin Pump market generated more than US$ 160 Million in 2016

• The US is the major market share holder for the North America Insulin Pump Market

Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle–compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.

“North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022” provides a deep and thorough evaluation of the North America Insulin Pump Market. The report provides an in–depth analysis of the type 1, type 2, newly diagnosed type 1 diabetes and overall diabetes population of all the three countries covered in the report. It provides an essential insights of insulin pump users in terms of volume in detail for latest trends, outlook and opportunities in all the three countries covered in the report.

Market outlook in value terms has been analyzed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Key trends in terms of collaborations, partnerships and licensing agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the North America Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation, Tandem Diabetes Care, Microport and Sooil Development. The major market players are evaluated on various parameters such as company overview, product outlook, latest development and trends and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States, Canada & Mexico Diabetes Population Analysis (2011 – 2022)
• North America Insulin Pump Users & Market Prospect & Growth (2011 – 2022)
• North America Insulin Pump Users & Market Share – By Countries (2011 – 2022)
• North America Insulin Pump Market Analysis – By Countries (2011– 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• Canada Insulin Pump Users and Market Analysis (2011 – 2022)
• Mexico Insulin Pump Users and Market Analysis (2011 – 2022)
• North America (All 3 Countries) Insulin Pump Reimbursement & Regulation System
• North America Insulin Pump Market – Major Deal Types
• Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the North America Insulin Pump Market
• Key Companies Analysis

Major Countries Covered in This Report:

• United States
• Canada
• Mexico

Major Companies Covered in This Report:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation and
• Tandem Diabetes Care
• Microport
• Sooil Development
"

Published

Read more
"United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022 "

"United States Insulin Pump Market is likely to reach USD 4 Billion by the year end of 2022.

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.

The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• United States Insulin Pump Market: Reimbursement & Regulation System
• United States Insulin Pump Market – Major Deal Types
• Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Insulin Pump Market

Key Companies Covered in the Report are as follows:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation
• Tandem Diabetes Care
"

Published

Read more
"United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022 "

"United States Insulin Pen Market is expected to reach more than US$2.5 Billion by 2022.

Market growth can be attributed to factors such as diabetes patient population, user–friendly design, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs and technological advancements in the field of insulin pen devices. However, low patient awareness, lack of device education and training among physicians and perception of the higher cost is expected to hamper growth of the market during forecast period.

“United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” provides a deep and thorough evaluation of the United States Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pen Market.

The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Users (2011 – 2022)
• United States Insulin Pen Users (2011 – 2022)
• United States Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
• United States Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
• United States Insulin Pen Market (2011 – 2022)
• United States Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
• United States Prefilled (Disposable) Insulin Pen Market (2011 – 2022)
• United States Insulin Pen Market: Reimbursement & Regulation System
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Insulin Pen Market

Key Companies Covered in the Report are as follows:

• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford
"

Published

Read more
Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

"Diabetes Disposable Insulin Pen Market is likely to reach more than US$ 9 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices

United States became the world’s biggest market of disposable insulin pen. United States market for disposable insulin pen is expected to reach more than US$ 2.5 Billion by the end of 2022. Japan will be the second–biggest market for disposable insulin pen which is expected to grow at a CAGR of X% by 2022. Germany is expected to be third biggest disposable insulin pen market being followed by Spain by the end of 2022.

The research report titled “Global Diabetes Disposable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the disposable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into disposable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the disposable insulin pen market.

The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly and Sanofi. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market.

All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints:

1. Overall Diabetes Population (2011 – 2022)
2. Insulin Users (2011 – 2022)
3. Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
4. Prefilled (Disposable) Insulin Pen Market (2011 – 2022)

Ten Major Markets(10MM) Covered in the Report are as follows:

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows:

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
"

Published

Read more
Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022

"Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of reusable insulin pen devices.

China is expected to lead the reusable insulin pen market with a total market share of over 50% by 2022. Germany has shown its potential to become leading #2 market with more than XX% market share in 2016 and is expected to maintain its #2 position during the forecast period. United States is expected to become the third largest reusable insulin pen market by 2022.

The research report titled “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the reusable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into reusable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the reusable insulin pen market.

The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market.

All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints

1. Overall Diabetes Population (2011 – 2022)
2. Insulin Users (2011 – 2022)
3. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
4. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)

Ten Major Markets(10MM) Covered in the Report are as follows:

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows:

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford

5. Ypsomed

6. Biocon Ltd.

"

Published

Read more
Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022

"Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market is likely to reach nearly USD 1.3 Billion by the year end of 2022.

Market growth can be attributed to factors such as Ideal Meetings Location, Unbeatable Event Spaces, Safety, Productive Atmosphere, Accommodations, International Accessibility, Enrichment Opportunities and Natural Wonders.

Japan, US West and US East MCI tourists play a significant role in contributing revenue to the Hawaii economy. Japan contributed more than 30% revenue followed by US East with more than 27% revenue in 2016. Japan is likely to maintain dominance in Hawaii MCI tourist’s revenue generator by the year end of 2022. US East and US West have shown its potential to become 2nd and 3rd major revenue generator countries by the year end of 2022. Other countries such as Other Asia, China and Canada emerge as the largest revenue generator in the Hawaii MCI Tourism Market.

The research report titled "" Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” provides detailed information on the Hawaii MCI Tourism Market. This report analyzes market data and provides a better understanding of MCI travelers flows and revenue to Hawaii. Market outlook in value terms for the forecasted period for Hawaii MCI tourism market has been detailed in the report. This report also entails a detailed description of market drivers and inhibitors of the Hawaii MCI tourism market.

This 65 Pages report with 52 Figures and 4 Tables have been analyzed from 5 viewpoints:

• Hawaii MCI Travelers, Revenue & Forecast (2013 – 2022)
• Hawaii MCI Travelers, Revenue Share & Forecast (2013 – 2022)
• Hawaii MCI Travelers, Revenue & Forecast – Top 12 Country Analysis (2013 – 2022)
• Hawaii MCI Tourism Market – Market Drivers
• Hawaii MCI Tourism Market – Inhibitors

Hawaii MCI Tourism Market – 12 Countries Covered

• US West
• US East
• Japan
• Canada
• Australia
• New Zealand
• Other Asia
• China
• Korea
• Taiwan
• Europe
• Latin America
"

Published

Read more
United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023

"United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023.

Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of new and advanced NIPT products. With increased patient access to NIPT test, United States NIPT test market is anticipated to have a positive outlook in the coming years.

The research report titled “United States Non-Invasive Prenatal Testing(NIPT) Market Insights, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2023” examines the market, competitive landscape and trends of the United States NIPT Test Market. The study provides an in–depth analysis of the actual and potential NIPT test market.

The report provides a decisive view on the NIPT Test volume and market in United States. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States NIPT Test Market. Additionally, the report includes insights into the NIPT implementation in the high-income countries. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States NIPT Test Market.

The report concludes with the profiles of major players in the United States NIPT Test Market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development and trends of the NIPT Test Market.


Key Topics Covered in the Report

• United States Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• United States Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• United States Average Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• United States Average Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• United States High Risk Actual NIPT Test Volume & Market Revenue (2015 - 2023)
• United States High Risk Potential NIPT Test Volume & Market Revenue (2015 - 2023)
• United States NIPT Test Market - Reimbursement & Regulation System
• NIPT Test Implementation in High–Income Countries
• United States NIPT Test Market - Comparative Test Analysis
• United States NIPT Test Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States NIPT Test Market

Key Companies Covered in the Report are as follows:

• Sequenom Laboratories (LabCorp)
• Ariosa Diagnostics (Roche)
• Illumina
• Natera
• Quest Diagnostics
"

Published

Read more
United States Blood Glucose Meter Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022

"United States Blood Glucose Meter Market is likely to reach USD 650 Million by the year end of 2022.

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes mellitus, improved glucose control and flexible, user–friendly design, government efforts for better management of diabetes mellitus and technological advancement in blood glucose meter devices.

The research report titled “United States Blood Glucose Meter Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Blood Glucose Meter Market. The study provides an in–depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. Moreover, it also provides an essential insight on insulin users.

The report provides a decisive view on the Blood Glucose Meter Users and Market. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States Blood Glucose Meter Market. Key trends in terms of collaboration, partnership, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Blood Glucose Meter Market. The report concludes with the profiles of major players in the United States Blood Glucose Meter Market. The key market players are evaluated on various parameters such as company overview, marketed products and latest development and trends of the Blood Glucose Meter Market.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• Insulin Users (2011 – 2022)
• United States Blood Glucose Meter Users and Market Analysis (2011 – 2022)
• United States Blood Glucose Meter Market: Reimbursement & Regulation System
• United States Blood Glucose Meter Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Blood Glucose Meter Market

Key Companies Covered in the Report are as follows:


• Roche
• LifeScan Inc
• Abbott Diabetes Care
• Arkray
• Ascensia Diabetes Care
• Fora Care
• Entra Health
• Fifty50 Medical
• Infopia
• Genesis Health Technologies
• iHealth Labs
• Oak Tree Health
• Livongo Health
• Nova Diabetes Care
• Sanofi Diabetes
• Telcare
• Walgreens
• U.S. Diagnostics
• Prodigy Diabetes Care
• Omnis Health
"

Published

Read more
Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022

"Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices

Insulin Pen Users Insights

China is the leading consumers of insulin pen where XX% of the diabetic population prefer insulin pen. India and Germany have shown its potential to become 2nd and 3rd popular insulin pen users. United States is the fourth leading consumers of insulin pen. Japan and Brazil hold the fifth and sixth leading consumers of insulin pen.

In terms of reusable insulin pen users, China gained its top position as the biggest overall consumer of reusable insulin pen. India and Germany grabbed the #2 and #3 position with XX% and XX% share in 2016 and is likely to maintain its position till the forecast period.

In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period

Insulin Pen Market Insights

United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period.

In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022.

In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period.

The research report titled “Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for Insulin Pen Market has been detailed in the report. The insulin pen market is further segment into reusable and prefilled insulin pen market. The report also explores detailed description of growth drivers and inhibitors of the Insulin Pen Market.

The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market.

All the Ten Major Markets(10MM) Covered in the Report Have Studied from 8 Viewpoints

1. Overall Diabetes Population (2011 – 2022)
2. Insulin Users (2011 – 2022)
3. Insulin Pen Users (2011 – 2022)
4. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
5. Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
6. Insulin Pen Market (2011 – 2022)
7. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
8. Prefilled (Disposable) Insulin Pen Market (2011 – 2022)

Ten Major Markets(10MM) Covered in the Report are as follows

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford
5. Ypsomed
6. Biocon Ltd.
"

 

Published

Read more
United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022

"United States Insulin Pump Market is likely to reach USD 4 Billion by the year end of 2022.

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.

The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• United States Insulin Pump Market: Reimbursement & Regulation System
• United States Insulin Pump Market – Major Deal Types
• Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Insulin Pump Market

Key Companies Covered in the Report are as follows:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation
• Tandem Diabetes Care
"

Published

Read more
High Intensity Focused Ultrasound (HIFU) System Market by Manufacturers, Research Sites, Clinical Trials, Deals Type, Key Trends & Opportunities to 2022

More than 570 commercial treatment sites treated over 115, 000 cases with HIFU system throughout the world with great success.

High Intensity Focused Ultrasound(HIFU) is a modality of therapeutic ultrasound and is a non–invasive method to deposit acoustic energy into tissue. In HIFU therapy, ultrasound beams are focused on diseased tissue, and due to the significant energy deposition at the focus, temperature within the tissue rises to 65° to 100°C, destroying the diseased tissue by coagulation necrosis. Each sonication of the beams treats a precisely defined portion of the targeted tissue.

Market growth can be attributed to factors such as increasing population base of cancer patients, technological advancements in HIFU devices, increasing number of commercial treatment centres, increasing demand for minimally invasive treatment procedures, and growing awareness regarding the benefits offered by HIFU procedures over those of conventional therapeutic.

The Research report presents a comprehensive assessment of the HIFU research sites, pre–clinical research sites, clinical research sites, technical research sites, commercial treatment sites and treatment by indication. Additionally, the report includes insight of clinical trials of the HIFU System. Key trends in terms of collaborations, distribution agreement and partnership deals are analyzed with details.

The report also includes comprehensive profiles of HIFU system manufacturers such Philips Healthcare, EDAP TMS, Sonacare Medical, Haifu Medical, Shanghai A&S Co., LTD, Mianyang Sonic Electronic Ltd., Insightec, Theraclion, Alpinion Medical Systems, FUS Instruments, Image Guided Therapy, Medsonic Ltd, Promedica Bioelectronics, Sumo Corporation Ltd and Mirabilis Medica. The thorough description of players includes parameters such as business overview, revenue, products analysis and recent development & trends of the manufacturers.

Global High Intensity Focused Ultrasound(HIFU) System Market – 15 Manufacturers covered

1) EDAP TMS
2) Philips Healthcare
3) Sonacare Medical
4) Haifu Medical
5) Shanghai A&S Co., LTD
6) Mianyang Sonic Electronic Ltd.
7) Insightec
8) Theraclion
9) Alpinion Medical Systems
10) FUS Instruments
11) Image Guided Therapy
12) Medsonic Ltd
13) Promedica Bioelectronics
14) Sumo Corporation Ltd
15) Mirabilis Medica
"

Published

Read more
Neuromodulation Market (By Application, Technology, Region and Company) and Forecast to 2021 – Global Analysis

The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.

North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.

Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.

Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021. The report also entails major drivers and challenges of neuromodulation market.

Neuromodulation Market: Segmentation

Neuromodulation market is classified on the basis of technology, application, company and geography.

Based on Technology, Neuromodulation market can be segmented as follows:

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Other Technologies

Based on Application, Neuromodulation market can be segmented as follows:

• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Other Applications

Based on Geography, Neuromodulation market can be segmented as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)

Based on Company, Neuromodulation market can be segmented as follows:

• Medtronic
• Boston Scientific
• St Jude Medical
• Liva Nova(Cyberonics)
• Nevro

Published

Read more
Global Neuroendovascular Coil and Non-Coil Devices Market – Growth, Trends and Forecasts (2016 - 2021)

The global neuroendovascular coil and non-coil devices market is estimated at US$ XX Billion in 2016 and projected to reach US$ XX Billion by 2021, growing at a CAGR of XX% during the forecast period.

Cerebrovascular diseases include some of the most common and devastating disorders: ischemic stroke and hemorrhagic stroke. According to the World Health Organization, 15 Million people suffer stroke worldwide each year. Of these, 5 Million die and another 5 Million are permanently disabled. Stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States. The incidence of cerebrovascular diseases increases with age, and the number of strokes is projected to increase as the elderly population grows, with a doubling in stroke deaths in the United States by 2030.

Drivers & Restraints

Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neuroendovascular devices and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neuroendovascular coil & non-coil devices market.

Device Insights

Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neuroendovascular coil & non-coil devices market with XX% market share by the end of 2021.

Country Insights

United States is seen as the dominant player in the neuroendovascular coil & non-coil devices market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.

Company Insights

Prudent analysis has been done on the competitor’s part, where four major players grab XX% of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes are the key influencers with their products in the neuroendovascular coil & non-coil devices market. New releases, merger & acquisitions, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, diseases, geographies, companies, price trend, pipeline products, type of coil & non-coil devices and competitive landscape. The report concludes with the profiles of major players in the global neuroendovascular coil & non-coil devices market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales figures of neuroendovascular coil & non-coil devices segment from 2012 to 2021. The report also entails major drivers and challenges of neuroendovascular coil & non-coil devices market.

Market Segmentation

Neuroendovascular coil & non-coil devices market can be segmented based on

• Device Type
• Disease Type
• Company
• Geography

Based on Device, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• Coil
• Carotid Stent
• Clot Removal
• Liquid Embolic
• Coil Assist Balloon
• Coil Assist Stent
• Flow Diverter Stent
• Micro wire/Catheter

Based on Disease, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• Aneurysm
• Intracranial Atherosclerotic Disease (ICAD)
• Ischemic Stroke
• Arteriovenous Malformation(AVM)

Based on Geography, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• United States
• France
• Germany
• Italy
• Spain
• United Kingdom
• Japan
• China
• India
• Brazil

Based on Company, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• Stryker
• Medtronic
• MicroVention (Terumo Corporation)
• De Puy Synthes

Published

Read more
Neurovascular Intervention Market Size, Market Share, Disease Analysis, Major Market Outlook, Product Analysis, Price Trend, Competitive Strategies and Forecast,2016 to 2021

The Global market for Neurovascular Intervention is projected to reach nearly US$4 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.

Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neurovascular interventional market.

United States is seen as the dominant player in the neurovascular intervention market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.

On the basis of device, Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neurovascular intervention market with XX% market share by the end of 2021.
Further, prudent analysis has been done on the competitor’s part, where four major players grab XX% of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes are the key influencers with their products in the Neurovascular Intervention market. New releases, merger & acquisitions, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, diseases, geographies, companies, price trend, pipeline products, type of devices and competitive landscape. The report concludes with the profiles of major players in the global neurovascular intervention market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of neurovascular intervention segment from 2012 to 2021. The report also entails major drivers and challenges of neurovascular intervention market.

The report covers in–depth analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2009 – 2015
• Market Size & Forecast 2016 to 2021
• Competition & Companies involved
• Merger & Acquisitions
• Price Trend
• Pipeline Products Analysis
• Market Growth Drivers and Challenges

Neurovascular Intervention Market: Segmentation

Neurovascular Interventional market is classified on the basis of device type, disease type, company and geography.

Based on Device, the global neurovascular intervention market can be segmented as follows:

• Coil
• Carotid Stent
• Clot Removal
• Liquid Embolic
• Coil Assist Balloon
• Coil Assist Stent
• Flow Diverter Stent
• Micro wire/Catheter

Based on Disease, the global neurovascular intervention market can be segmented as follows:

• Aneurysm
• Intracranial Atherosclerotic Disease (ICAD)
• Ischemic Stroke
• Arteriovenous Malformation(AVM)

Based on Geography, the global neurovascular intervention market can be segmented as follows:

• United States
• France
• Germany
• Italy
• Spain
• United Kingdom
• Japan
• China
• India
• Brazil

Based on Company, the global neurovascular intervention market can be segmented as follows:

• Stryker
• Medtronic
• MicroVention (Terumo Corporation)
• De Puy Synthes

Published

Read more
Breast Implants Market Global Analysis and Forecast 2016 – 2022

Breast augmentation is one of the most popular cosmetic surgical procedures worldwide. The breast implants market is expected to grow at a steady pace driven by the popularity of breast augmentation procedures, rise in the disposable income of women, increasing beauty consciousness among the people. Furthermore, rising consumer awareness, greater emphasis to look good or aesthetic appearance, technology advancement and innovation are some of the other key driving factors in breast implants market.

Long–term Outlook: The global breast implants market, has witnessed a steady growth and is anticipated to grow with a healthy CAGR during the forecast period.

Breast Implants Market: Segment wise Outlook

The silicone breast implants segment is expected to grow at fast pace because of the popularity of highly cohesive silicone implants made of high strength silicone gel and textured with silicone shell. Silicone is the most preferred breast implants worldwide. It accounted for more than 80% market share in 2015. It is projected that silicone breast implants will gain the highest market share in the forecast period.

Breast Implants Market: Region wise Outlook

The Americas dominated the market, followed by the EMEA and APAC. The breast implants market in APAC is expected to grow at a faster pace than the market in the Americas because of the high acceptance of the procedure in China and South Korea. In the EMEA, the breast implants market is expected to grow slowly because of the safety concerns and decrease in spending power. It is likely that the Americas will lead the breast implants market with more than 60% market share by the year 2022.


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. This report provides detailed analysis of global markets for breast implants from 2014-2015, and provides extensive market forecasts (2016-2022) by region/country and subsectors. The report covers key technological developments in the recent times and profiles leading players in the market and analyses their recent key development. The major players in the global breast implants market are Allergan, Mentor Worldwide, GC Aesthetics, Establishment Labs, Groupe Sebbin, Laboratories Arion, Kangning, Guangzhou Wanhe Plastic Materials and Sientra. The report also entails major drivers and challenges of breast implants market.

The report covers in–depth analysis on:

• Breast Implants Market Segments
• Breast Implants Market Dynamics
• Historical Actual Market Size, 2014 – 2015
• Market Size & Forecast 2016 to 2022
• Competition & Companies involved
• Market Growth Drivers and Challenges

Global Breast Implants Market is segmented as follows:

Breast Implants Market & Forecast (2014 –2022)

Breast Implants Market Share & Forecast (2014 – 2022)

• Breast Implants Segment Wise Market Share
• Breast Implants Region Wise Market Share

Breast Implants Market – By Segment

• Silicone Breast Implants
• Saline Breast Implants

Breast Implants Market: By Geography

• The Americas
• United States
• Rest of the Americas
• Europe, Middle East, & Africa (EMEA)
• Asia Pacific(APAC)

Cost Analysis of Breast Implant Procedures

Market Segmentation by Surgical Procedures

• Breast Augmentation
• Breast Reconstruction

Key Companies Analysis

• Allergan
• GC Aesthetics
• Mentor Worldwide LLC
• Sientra
• Arion Laboratories
• Establishment Labs
• Groupe Sebbin
• Guangzhou Wanhe Plastic Materials
• Kangning

Global Breast Implants Market: Growth & Challenges

Published

Read more
Global Hip and Knee Orthopedic Surgical Implants Market Analysis to 2021

Global Hip & Knee Orthopedic Surgical Implants market is projected to reach more than US$ 12 Billion by 2021, at a CAGR of XX% from 2016 to 2021. The growing prevalence of symptomatic osteoarthritis and post–traumatic arthritis due to the growing aging segment of the population across the globe will continue to drive growth in the hip & knee orthopedic surgical implants market. Increasing life spans and lifestyles impact the number of individuals with joints subject to failure, thereby increasing demand for hip & knee replacement procedures. Additionally, the growing health awareness among masses, along with increase in the spending capacity of the population are propelling the market growth.

Hip & Knee Orthopedic Surgical Implants Market: Country–wise Outlook
United States is seen as the dominant player in the hip & knee orthopedic surgical implants market. International markets such as India, China and Japan will show positive growth in the future and market share will increase to XX% by the year 2021. The opportunity is immense in the emerging markets, as there is a large untapped population with hip and knee orthopedic surgical implants need.

Hip & Knee Orthopedic Surgical Implants Market: Key Players Outlook
The global hip & knee orthopedic surgical implants market is dominated by Zimmer Biomet, Stryker, DePuy Synthes and Smith & Nephew. The three large players in the hip & knee orthopedic surgical implants market are Zimmer Biomet, DePuy Synthes and Stryker combined, they comprise almost more than XX% of the market. Other nominal yet important players of this market include, Exactech, DJO Global, Smith & Nephew and many more. It is expected that Zimmer Biomet will emerge as a leading company in the hip & knee orthopedic surgical implants market.


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. The report concludes with the profiles of major players in the global hip and knee orthopedic surgical implants market such as Zimmer Biomet, Stryker, Smith & Nephew, Exactech, DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of hip and knee implants from 2008 to 2021.

The report covers in–depth analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2008 – 2015
• Market Size & Forecast 2016 to 2021
• Competition & Companies involved
• Deals Landscapes
• Market Growth Drivers and Challenges

Global Hip & Knee Orthopedic Surgical Implants Market is segmented as follows:

• Global – Hip & Knee Implants Market & Forecast (2008 – 2021)

• Global – Hip & Knee Implants Market Share & Forecast (2008 – 2021)

• Global – Hip Implants Market & Forecast (2008 – 2021)

• Global – Knee Implants Market & Forecast (2008 – 2021)


Global – Hip Implants Market Share & Forecast (2008 – 2021)

• Company Market Share Outlook
• Country Market Share Outlook

Global – Knee Implants Market Share & Forecast (2008 – 2021)

• Company Market Share Outlook
• Country Market Share Outlook

Global - Hip Implants Market – Country Outlook

• United States
• Germany
• Italy
• France
• Spain
• United Kingdom
• Japan
• Brazil
• China
• India

Global - Knee Implants Market – Country Outlook

• United States
• International


Global – Hip & Knee Implants Market: Key Company Analysis

• Zimmer Biomet
• Stryker
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew
• Exactech
• Other Companies

Global Hip & Knee Implants Market: Deals Landscape

• Merger & Acquisitions
• Partnerships
• Collaboration
• Distribution Agreement

Global Hip & Knee Implants Market: Growth & Challenges

Published

Read more
Knee Implants Market: Global Industry Analysis and Market Forecast 2016 – 2021

The global market overview for knee implants looks promising considering advances in computer–assisted total knee implants as well as other technological platforms. The knee implants market will continue to grow due to an aging population in much of the world. Increasing life spans and lifestyles impact the number of individuals with knee subject to failure, thereby increasing demand for knee replacement procedures. Additionally, the growing health awareness among masses, along with increase in the spending capacity of the population are propelling the market growth.
Long–term Outlook: Global knee implants market is projected to reach more than US$ 7 Billion by 2021, at a CAGR of XX% from 2016 to 2021.
Knee Implants Market: Country–wise Outlook
United States hold the highest share with more than 60% in 2015, and is expected that United States will maintain its position in the forecasting period. International markets such as India, China and Japan will show positive growth in the future and market share will increase to XX% by the year 2021. The opportunity is immense in the emerging markets, as there is a large untapped population with the surgical need of knee implants.
Knee Implants Market: Key Players Outlook
The global knee implants market is dominated by Zimmer Biomet, Stryker, DePuy Synthes and Smith & Nephew. The three large players in the knee implants market are Zimmer Biomet, DePuy Synthes and Stryker combined, they comprise almost more than 80% of the market. Other nominal yet important players of this market include Smith & Nephew, Exactech, DJO Global and many more. It is expected that Zimmer Biomet will emerge as a leading company in the knee implants market in the forecasting period.


The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. The report concludes with the profiles of major players in the global knee implants market such as Zimmer Biomet, Stryker, Smith & Nephew, Exactech, DePuy Synthes(JnJ). The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of knee implants from 2008 to 2021.

The report covers in–depth analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2008 – 2015
• Market Size & Forecast 2016 to 2021
• Competition & Companies Involved
• Deals Landscapes
• Market Growth Drivers and Challenges

Global Knee Implants Market is segmented as follows:

Global – Knee Implants Market & Forecast (2008 – 2021)

Global – Knee Implants Market Share & Forecast (2008 – 2021)

• Company Market Share Outlook
• Country Market Share Outlook

Global Replacement Knee Implants Market – Country Outlook

• United States
• International

Global – Knee Implants Market: Key Company Analysis

• Zimmer Biomet
• Stryker
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew
• Exactech
• Other Companies

Global Knee Implants Market: Deals Landscape

• Merger & Acquisitions
• Partnerships
• Collaboration
• Distribution Agreement

Global Knee Implants Market: Growth & Challenges

Published

Read more
Global Epileptic Seizure Monitor Alarm System Sales Market Report 2018

In this report, the global Epileptic Seizure Monitor Alarm System market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Epileptic Seizure Monitor Alarm System for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Epileptic Seizure Monitor Alarm System market competition by top manufacturers/players, with Epileptic Seizure Monitor Alarm System sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
MC10
Emfit
Hipass Design
Smart Monitor
Empatica
Telecare24
ITS Designs Ltd
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Wearable Devices
Camera Devices
Mattress Devices
Anti-suffocation Pillows

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Pharmacy Stores
E-commerce
Drug Stores
Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Published

Read more
Embolic Protection Devices Sales Market Global Report 2018

In this report, the global Embolic Protection Devices market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Embolic Protection Devices for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Embolic Protection Devices market competition by top manufacturers/players, with Embolic Protection Devices sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Medtronic
Abbott Laboratories
Boston Scientific
Cordis (A Cardinal Health Company)
Contego Medical
W. L. Gore & Associates
Silk Road Medical
Claret Medical
Allium Medical Solutions
Angioslide

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Distal Filter Devices
Distal Occlusion Devices
Proximal Occlusion Devices

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Ambulatory Care Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Published

Read more
Global Electrosurgical Tools Sales Market Report 2018

In this report, the global Electrosurgical Tools market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Electrosurgical Tools for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Electrosurgical Tools market competition by top manufacturers/players, with Electrosurgical Tools sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Medtronic
Acoma Medical
Omnimed
SurgRx
Perlong
Stryker
B Braun
CONMED
Olympus
Karl Storz
Johnson & Johnson
Doral Medical
Applied Medical
ALSA
Bovie Medical
klsmartin
ANA-MED
Special Medical Technology
Ellman International
ITC
Seeuco Electronics Technology

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Radio Frequency
Ultrasonic
Molecular Resonance

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Veterinary
Dental
Cardiology
ENT
Dermatology
Urology
Ophthalmology
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Published

Read more
Global Electrosurgery Sales Market Report 2018

In this report, the global Electrosurgery market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Electrosurgery for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Electrosurgery market competition by top manufacturers/players, with Electrosurgery sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Ethicon
Covidien
B. Braun Melsungen
CONMED Corporation
BOWA-electronic
Erbe Elektromedizin
Bovie Medical Corporation
Olympus Corporation

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Gynecology Surgery
Urologic Surgery
Cosmetic Surgery
Orthopedic Surgery
Cardiovascular Surgery
Neurosurgery

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Published

Read more
Global Electrosurgery Instruments Sales Market Report 2018

In this report, the global Electrosurgery Instruments market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Electrosurgery Instruments for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Electrosurgery Instruments market competition by top manufacturers/players, with Electrosurgery Instruments sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Ethicon
Covidien
B. Braun Melsungen
Erbe Elektromedizin
Bovie Medical Corporation
Olympus Corporation
CONMED Corporation
BOWA-electronic

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Bipolar
Monopolar

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

 

Published

Read more
ECG Monitoring Systems Sales Market Global Report 2025

In this report, the global ECG Monitoring Systems market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of ECG Monitoring Systems for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global ECG Monitoring Systems market competition by top manufacturers/players, with ECG Monitoring Systems sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
GE Healthcare
Philips Healthcare
Nihon Kohden
Schiller AG
Opto Circuits
Cardionet
Spacelabs Healthcare
Mindray Medical
Compumed Inc
Welch Allyn
Fukuda Denshi
Biotronik Inc.
Draeger
Omron Healthcare
Penlon
Bionet
Mortara
CAS Medical System
Mediana
Guangdong Biolight Meditech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Rest ECG Recorders
ECG Stress Testing Systems
Event Recorders
Holter Monitors
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Home Care
Research Center
Physician Office
Nursing Homes
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Casting and Splinting Products Sales Market Global Report 2025

In this report, the global Casting and Splinting Products market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Casting and Splinting Products for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Casting and Splinting Products market competition by top manufacturers/players, with Casting and Splinting Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
3M
Bird & Cronin Inc.
BSN Medical
Corflex
DeRoyal Industries
DJO Global
Orfit Industries
Patterson Medical Holdings
Prime Medical
Spencer Italia
Stryker Corporation
Zimmer Biomet
Ossur

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Casting Products
Splinting Products

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Homecare Settings
Specialty Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Carotid Stent Sales Market Global Report 2025

In this report, the global Carotid Stent market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Carotid Stent for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Carotid Stent market competition by top manufacturers/players, with Carotid Stent sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Vascular
Boston Scientific
Covidien
Gore Medical
InspireMD
Medtronic
Terumo
Optimed
Cardinal Health

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
PTA
CAS
CEA

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Vascular Surgery
Neurosurgery
Cardiology

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Cardiovascular Medical Devices Sales Market Global Report 2018

In this report, the global Cardiovascular Medical Devices market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cardiovascular Medical Devices for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Cardiovascular Medical Devices market competition by top manufacturers/players, with Cardiovascular Medical Devices sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Medtronic
St. Jude Medical
Boston Scientific
Edwards Lifesciences
Abbott Laboratories
Johnson & Johnson
Getinge
Terumo
W. L. Gore & Associates
Lepu Medical Technology
Sorin Group
B.Braun
Tegra
Demax Medical
Newtech Medical Devices
Argon Medical Devices
Eurocor
Gore
Merit Medical Systems
SynexMed

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Cardiac Rhythm Management Devices
Interventional Cardiac Devices
Cardiac Prosthetic Devices
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Bone Cement Gun Sales Market Global Report 2025

In this report, the global Bone Cement Gun market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Bone Cement Gun for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Bone Cement Gun market competition by top manufacturers/players, with Bone Cement Gun sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Heraeus Medical
AAP Biomaterials
Exactech
Orthopaedic Innovation
Stryker
Cardinal Health
Armstrong Medical
Shenyang Pusiman
Beijing Montagne

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Bench-Top Bone Cement Gun
Portable and Hand-Held Bone Cement Gun

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Clinic
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Joint Reconstruction Devices Report on Global and United States Market, Status and Forecast, by Players, Types and Applications 2018-2025

This report studies the Joint Reconstruction Devices market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Joint Reconstruction Devices market by product type and application/end industries.

The global Joint Reconstruction Devices market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Joint Reconstruction Devices.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Joint Reconstruction Devices in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States market, including
Medtronic
Nuvasive, Inc.
Zimmer Biomet
Stryker
DePuy Synthes
Aesculap Implant Systems, LLC
Smith and Nephew
CONMED Corporation
DJO Global, Inc

On the basis of product, the market is primarily split into
Bone Graft
Implants
Osteotomy
Arthroscopy
Others

On the basis on the end users/application, this report covers
Knee
Hip
Shoulder
Ankle
Others

Published

Read more
Artificial Hip Joint Report on Global and United States Market, Status and Forecast, by Players, Types and Applications 2018-2025

This report studies the Artificial Hip Joint market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Artificial Hip Joint market by product type and application/end industries.

The global Artificial Hip Joint market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Artificial Hip Joint.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Artificial Hip Joint in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States market, including
Zimmer Biomet Holdings
Johnson & Johnson
Stryker Corporation
Smith & Nephew
MicroPort Scientific Corporation
Exactech, Inc.
DJO Global, Inc.
B. Braun

On the basis of product, the market is primarily split into
By Joint Interface Material
By Fixed Type

On the basis on the end users/application, this report covers
Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers
Others

Published

Read more
Artificial Knee Joint Market

This report studies the Artificial Knee Joint market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Artificial Knee Joint market by product type and application/end industries.

The global Artificial Knee Joint market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Artificial Knee Joint.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Artificial Knee Joint in these regions, from 2013 to 2025 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States market, including
B. Braun
Smith & Nephew
Zimmer Biomet Holding Inc.
Stryker
Exactech
Johnson & Johnson
DJO Surgical
Medtronic
Becton Dickinson
Arthrex, Inc.
ConforMIS
MicroPort Scientific Corporation
OMNI life science

On the basis of product, the market is primarily split into
By Material
By Fixed Type

On the basis on the end users/application, this report covers
Hospitals
Specialized Orthopedic Clinics
Ambulatory Surgical Centers

Published

Read more
Point of Care Testing – Global Analysis & Market Forecasts

Point of care (POC) technologies are rapidly becoming part of the revolution of the healthcare landscape. With evolving high–tech innovations in healthcare, including smartphone apps, biosensors, lab–on–a chip, and wearable devices—all of which offer a closer connection to the patient. The dynamic of point of–care testing (POCT) is to bring testing closer to the patient and results conveniently and quickly to the provider to expedite diagnosis and subsequent treatment. POCT allows for faster clinical decisions in hospitals, physicians’ offices, ambulances, patient homes, and in the field.

The global point of care testing market is projected to reach US$ 38 Billion by 2022, at a CAGR of XX% from 2016 to 2022. The global market is mainly driven by increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home–based POC devices, and technological advancements with regard to development of advanced, faster, and easy to–use devices are stimulating the demand for POCT

This report titled “Point of Care Testing – Global Analysis & Market Forecasts” provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals and collaboration deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.

The following 13 segments of the point of care testing market are detailed with market size and six year forecast.

• Blood Glucose Testing
• Cardiac Markers Testing
• Lipid Panel/Cholesterol Testing
• Blood Coagulation Testing
• Infectious Disease Testing
• Urinalysis Testing
• Drug of Abuse Testing
• Pregnancy & Fertility Testing
• Cancer Markers Testing
• Critical Care Testing
• HbA1C Testing
• Clinical Chemistry Testing
• Bilirubin Testing

This report also gives access to significant data such as:

• Market Growth Drivers in the Point of Care Testing Market
• Challenges in the Point of Care Testing Market
• Current Market Trends
• Market Forecasting for the Coming Years
• Merger & Acquisitions between major companies
• Distribution Agreement
• Licensing Deals
• Collaboration Deals

 

Published

Read more
Medical Waste Management Market Global Research Report 2018

 In this report, the global Medical Waste Management market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Medical Waste Management in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Medical Waste Management market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Stericycle (US)
Sharps Compliance (US)
Veolia Environment (US)
Daniels Sharpsmart (US)
Clean Harbors (US)
MedWaste Management (US)
ATI (US)
Republic Services (US)
Waste Management (US)
Medical Waste Services (US)
Excel Medical Waste (US)
Cyntox (US)
Triumvirate (US)
BioMedical Waste Solutions (US)
UMI (US)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Technology
Incineration
Autoclaves
Microwave
Type II

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals
Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want

Published

Read more
Lab Automation Market - Global Industry Analysis and Opportunities Assessment 2012 – 2022

Automation is one of the best weapon in the life science laboratory due to the growing demands for productivity in speed, accuracy, throughput and efficiency. Helped by advance technology, contemporary automated systems are already adept of a wide range of functions that were previously performed by slow, tedious and manual labor. Instrumentation continues to evolve, and is poised to tackle tasks that were not even conceivable just a few years ago. Originally used mostly by the big pharmaceutical and biotechnology companies, laboratory automation technology has quickly developed to satisfy a larger pool of clinical experts in the life science industry. Automation companies not only produce automation for specific customer needs but also smaller, easy-to-use systems that are much more accessible to clinical experts to satisfy their general needs. It is likely that Lab Automation market will reach more than US$ 16 Billion by the year 2022.

Clinical Automation Laboratory Market Analysis: In the clinical automation laboratory market, United States is seen as the dominant player followed by Europe and Japan will likely become second and third largest market. In terms of application, Work Station and LIMS are the leading market share taker in clinical laboratory automation market. It is anticipated that work station will lead the clinical lab automation market by the year 2022 followed by LIMS in 2nd position. Other applications of clinical lab automation such as sample transport system and specimen handling system will spot in 3rd and 4th position in clinical laboratory automation market.

Drug Discovery Automation Market Analysis:  In the drug discovery automation market, United States is the hub for drug discovery. In 2015, United States hold XX% share of drug discovery automation market, which is expected to increase XX% by the year 2022. In terms of application, Plate readers has emerged as the largest market share taker in the drug discovery automation market followed by automated liquid system.

DPI Research report titled “Lab Automation Market - Global Industry Analysis and Opportunities Assessment 2012 – 2022” presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and major deals in the Lab Automation Industry.

Lab Automation Market has been analysed from 3 viewpoints:

1) Market and Forecast (2012 - 2022)
2) Segment wise Market & Forecast (2012 - 2022)
4) Region wise Lab Automation Market & Forecast (2012 - 2022)

Lab Automation Market - Application Segments Covered in the Report are:

1. Clinical Automation Laboratory
2. Drug Discovery Automation

The following segments of the Clinical Automation Laboratory market are detailed with size and six year forecast.

• Work Station
• Sample Transport System
• Storage Retrieval System
• Specimen Handling System
• Laboratory Information Management System (LIMS)

Furthermore, the following segments of the Drug Discovery Automation market are detailed with size and six year forecast.

• Automated Liquid Handling System
• Robotics
• Plate Readers
• Dissolution Testing
• Storage Retrieval System
• Laboratory Information Management System (LIMS)

The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include:

• United States
• Europe
• Japan
• Brazil, Russia, India, China(BRIC)
• Rest of the world

Data Sources
 
The information contained in this report is based on both primary and secondary sources.
 
Primary Sources: Questionnaires, Surveys, telephonic interviews with industry experts and Observations
 
Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

 

Published

Read more
Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) - Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 – 2021

Non-Invasive Prenatal Test (NIPT) are targeted at the detection of certain specific chromosomal aneuploidies from maternal blood sample in pregnant women at high risk for fetal aneuploidies. Currently, the prenatal testing market is experiencing a paradigm shift from conventional prenatal screening and diagnostic methods to non-invasive prenatal testing. This is mainly because of the advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for common chromosomal abnormalities.

NIPT is one of the most promising new areas of screening because it delivers highly actionable insights for empowering critical health decisions. The global non-invasive prenatal testing market is segmented on the basis of tests viz; Harmony, MaterniT21 PLUS, PrenaTest, Verifi, BambniTest, Panorama, InformaSeq, Non-Invasive Fetal Trisomy Test (NIFTY), VisibiliT, Veracity and IONA Test. NIPT has experienced substantial growth over the past few years.

MaterniT21 plus test has gain its momentum in 2011 when there was only one NIPT test available in the market. In 2015, The MaterniT21 plus test market revenue decreased with XXX% compared to 2014. MaterniT21 test market revenue value was US$ XXX Million in 2015. Natera has emerged as one of the leading companies, with innovative technologies and a strong commercial base. Natera Panorama test will lead the NIPT market in the forecasting period with the market share of XXX% by the year 2021. Other NIPT tests such as Harmony, Verifi and NIFTY have emerged as the promising test in the NIPT test market. The major companies are expanding their tests through Collaboration, Distribution Agreement, Strategic Alliances and Partnerships with Clinical Laboratories and Hospitals.

DPI Research report titled Non-Invasive Prenatal Testing (NIPT) Market (Panorama, Bambni Test, Harmony, MaterniT21 PLUS, NIFTY, PrenaTest, Verifi, VisibiliT, informaSeq, Veracity, IONA Test) - Global Market Analysis, Size, Volume, Share, Growth, Trends and Forecast 2011 – 2021. The report presents a comprehensive study of the Global NIPT market with market revenue and volume of the tests. market shares for leading NIPT test, comparative analysis of the non–invasive prenatal testing, NIPT implementation in HICs and LMICs, major deals in the NIPT market such as Collaborations, Partnerships, Distribution Agreement, Venture Capital Investment, Merger & Acquisition, Licensing Agreement and Exclusive Agreement. The report also covers market growth drivers, challenges, current and upcoming trends of the NIPT test market

Key segments of the Global NIPT market

The 11 NIPT Test covered in the report has been analyzed from 2 viewpoints:

1. NIPT Test Market Revenue (2011 - 2021)
2. NIPT Test Volume (2011 - 2021)

The following are the NIPT test name which is covered in the report.

1) BambniTest
2) Harmony
3) informaSeq
4) MaterniT21 PLUS
5) NIFTY
6) Panorama
7) PrenaTest
8) verifi
9) VisibiliT
10) Veracity
11) IONA Test

The report also covers NIPT implementation in High Income Countries and Low - or- Middle Income Countries. The 3 issues for implementation covered are:

1) Clinical Issues
2) Ethical Issues
3) Legal and Regulatory Issues


This report gives access to significant data such as:

• Market Growth Drivers
• Challenges in the NIPT Test Market
• Current Market Trends
• Market Forecasting for the Coming Years
• Comparative Test Analysis

Data Sources
 
The information contained in this report is based on both primary and secondary sources.
 
Primary Sources: Questionnaires, Surveys, telephonic interviews with industry experts and Observations
 
Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

 

Published

Read more
Hearing Aids Market Global Research Report 2025

In this report, the global Hearing Aids market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hearing Aids in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Hearing Aids market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Zounds Hearin(U.S.)
SeboTek Hearing Systems, LLC (U.S.)
Sivantos Pte(Singapore)
GN Store Nord A/S (Denmark)
Cochlear Limited (Australia)
Sonova (Switzerland)
MED-EL (Austria)
William Demant Holding A/S (Denmark)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
In the ear hearing aids (ITE)
In the canal (ITC)
Completely in the canal (CIC)
Behind the ear (BTE)
Receiver in canal (RIC)

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital
Clinic
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more
Telemedicine Market Global Size, Status and Forecast 2022

This report studies the global Telemedicine market, analyzes and researches the Telemedicine development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Aerotel Medical Systems
Bosch Healthcare
AMD Telemedicine
GE Healthcare Ltd.
Philips Healthcare
McKesson Ltd.
Honeywell Life Care Solutions

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Telemedicine can be split into
Telehome
Telehospital/Clinic

Market segment by Application, Telemedicine can be split into
Telepathology
Teleradiology
Telecardiology
Telepsychiatry

If you have any special requirements, please let us know and we will offer you the report as you want.

Published

Read more

SORT BY PRICE







REPORT TYPE

  • USA Office

    244 , Madison Avenue
    New York City, NY - 10016
    United States


    UK Office

    109 ,Straford Street,Leeds
    West Yorkshrie LS11 6JG
    United Kingdom

Copyright © 2018-19 futuregenicreports.com. All rights reserved.